Da Huang
- Topics
- Ubiquitin and proteasome pathways (6 papers)Cancer Mechanisms and Therapy (3 papers)Epigenetics and DNA Methylation (3 papers)
In The Last Decade
Da Huang
22 papers receiving 309 citations
Peers
Comparison fields: 5 of 52
- Molecular Biology 256
- Cancer Research 118
- Oncology 75
- Cell Biology 38
- Immunology 36
Countries citing papers authored by Da Huang
This map shows the geographic impact of Da Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Huang more than expected).
Fields of papers citing papers by Da Huang
This network shows the impact of papers produced by Da Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Huang. The network helps show where Da Huang may publish in the future.
Co-authorship network of co-authors of Da Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Da Huang. A scholar is included among the top collaborators of Da Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da Huang. Da Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 28 | |
| 9 | 1 | |
| 10 | 6 | |
| 11 | 21 | |
| 12 | 20 | |
| 13 | 11 | |
| 14 | ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation. | 20 |
| 15 | 10 | |
| 16 | 61 | |
| 17 | Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma. | 14 |
| 18 | 26 | |
| 19 | 19 | |
| 20 | 40 |
About Da Huang
Da Huang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 23 papers that have together received 310 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Cancer Mechanisms and Therapy (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (118 citations), Molecular Biology (256 citations) and Oncology (75 citations). Da Huang has collaborated with scholars based in China and Ethiopia. Frequent co-authors include Leifeng Chen, Jianghua Shao, Rongfa Yuan, Liang Hao, Ming Li, Haibin Hao, Yumin Qiu, Tiande Liu, Fang Li and Zhiming Liao. Their work appears in journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.